 Home > Medical News > Latest Medical News > Remission rate reaches 62% Janssen submits bispecific antibody marketing application

Remission rate reaches 62% Janssen submits bispecific antibody marketing application

 Last Update: 2022-01-08
 Source: Internet
 Author: User

Tags

adpkd treatment

written application

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, Johnson & Johnson's Janssen Company (Janssen) announced that it has submitted a biologics license application (BLA) for teclistamab to the US FDA for the treatment of relapsed or refractory (R/R) multiple myeloma (MM) Patient

MM is a malignant disease caused by the abnormal proliferation of clonal plasma cells.

BCMA is a popular target for the treatment of B-cell blood cancers and is highly expressed in multiple myeloma cells

The submission of this BLA is supported by the positive results of a multi-center Phase 1/2 clinical trial evaluating the efficacy and safety of teclistamab

Reference materials:

[1] Janssen Submits Biologics License Application to US FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.

[2] New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pretreated Patients with Multiple Myeloma.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.